Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection

Martin Lagging; Nina Langeland; Court Pedersen; Martti Färkkilä; Mads Rauning Buhl; Kristine Mørch; Amar P Dhillon; Asa Alsiö; Kristoffer Hellstrand; Johan Westin; Peer Christensen; Peter Leutscher; Gunnar Norkrans; NORDynamIC Study Group

doi:10.1002/hep.22450

Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection

Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilä, Mads Rauning Buhl, Kristine Mørch, Amar P Dhillon, Asa Alsiö, Kristoffer Hellstrand, Johan Westin, Peer Christensen, Peter Leutscher, Gunnar Norkrans, NORDynamIC Study Group

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

14 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Hepatology
Vol/bind	48
Udgave nummer	2
Sider (fra-til)	695
ISSN	0270-9139
DOI	https://doi.org/10.1002/hep.22450
Status	Udgivet - 29 jul. 2008
Udgivet eksternt	Ja

Adgang til dokumentet

10.1002/hep.22450

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Lagging, M., Langeland, N., Pedersen, C., Färkkilä, M., Buhl, M. R., Mørch, K., Dhillon, A. P., Alsiö, A., Hellstrand, K., Westin, J., Christensen, P., Leutscher, P., Norkrans, G., & NORDynamIC Study Group (2008). Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection. Hepatology, 48(2), 695. https://doi.org/10.1002/hep.22450

@article{7bb570ed587c4752a5ed5a48c0110065,

title = "Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection",

keywords = "Antiviral Agents/administration & dosage, Body Weight, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Genotype, Hepacivirus/genetics, Hepatitis C, Chronic/blood, Humans, Interferon alpha-2, Interferon-alpha/administration & dosage, Polyethylene Glycols/administration & dosage, RNA, Viral/blood, Recombinant Proteins, Ribavirin/administration & dosage, Time Factors",

author = "Martin Lagging and Nina Langeland and Court Pedersen and Martti F{\"a}rkkil{\"a} and Buhl, {Mads Rauning} and Kristine M{\o}rch and Dhillon, {Amar P} and Asa Alsi{\"o} and Kristoffer Hellstrand and Johan Westin and Peer Christensen and Peter Leutscher and Gunnar Norkrans and {NORDynamIC Study Group}",

year = "2008",

month = jul,

day = "29",

doi = "10.1002/hep.22450",

language = "English",

volume = "48",

pages = "695",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Wiley",

number = "2",

}

Lagging, M, Langeland, N, Pedersen, C, Färkkilä, M, Buhl, MR, Mørch, K, Dhillon, AP, Alsiö, A, Hellstrand, K, Westin, J, Christensen, P, Leutscher, P, Norkrans, G & NORDynamIC Study Group 2008, 'Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection', Hepatology, bind 48, nr. 2, s. 695. https://doi.org/10.1002/hep.22450

Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection. / Lagging, Martin; Langeland, Nina; Pedersen, Court et al.
I: Hepatology, Bind 48, Nr. 2, 29.07.2008, s. 695.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

TY - JOUR

T1 - Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection

AU - Lagging, Martin

AU - Langeland, Nina

AU - Pedersen, Court

AU - Färkkilä, Martti

AU - Buhl, Mads Rauning

AU - Mørch, Kristine

AU - Dhillon, Amar P

AU - Alsiö, Asa

AU - Hellstrand, Kristoffer

AU - Westin, Johan

AU - Christensen, Peer

AU - Leutscher, Peter

AU - Norkrans, Gunnar

AU - NORDynamIC Study Group

PY - 2008/7/29

Y1 - 2008/7/29

KW - Antiviral Agents/administration & dosage

KW - Body Weight

KW - Dose-Response Relationship, Drug

KW - Drug Administration Schedule

KW - Drug Therapy, Combination

KW - Genotype

KW - Hepacivirus/genetics

KW - Hepatitis C, Chronic/blood

KW - Humans

KW - Interferon alpha-2

KW - Interferon-alpha/administration & dosage

KW - Polyethylene Glycols/administration & dosage

KW - RNA, Viral/blood

KW - Recombinant Proteins

KW - Ribavirin/administration & dosage

KW - Time Factors

U2 - 10.1002/hep.22450

DO - 10.1002/hep.22450

M3 - Comment/debate

C2 - 18666232

SN - 0270-9139

VL - 48

SP - 695

JO - Hepatology

JF - Hepatology

IS - 2

ER -